Encouraging Blood Donation in Patients With a Blood Type in Short Supply

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59093 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-15

Study Completion Date

2022-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As of November 2021, partly due to the COVID-19 pandemic, there has been a months-long national shortage of several types of blood in the U.S. (O-Pos, O-Neg, A-Neg, B-Neg, and AB-Neg), which has extended to a local blood shortage within the Geisinger community. The broad aim of this collaborative healthcare operations quality improvement project is to determine whether a message indicating that a patient's own blood type is in short supply increases the likelihood that they will donate, compared to a message that mentions a blood shortage without referencing the patient's blood type, or no message at all. Scientists in Geisinger's Behavioral Insights Team (BIT), part of Geisinger's Steele Institute for Health Innovation, will collaborate with Miller Keystone, where Geisinger refers patients who wish to donate blood and from whom Geisinger receives blood for clinical purposes. Patients with one of the needed blood types will be randomized to receive 1) a message about a blood shortage that does not specify the blood types in short supply or their own blood type (no-blood-type message), 2) the same message modified slightly to specify the recipient's blood type, and to mention that their blood type is in short supply (blood-type message), or 3) no message (shortage control group). A second no-contact control group of patients without any of the needed blood types will also be observed (no-shortage control group). Both the blood-type and no-blood-type messages are informed by behavioral science, emphasizing supply needs in local hospitals and providing community-relevant examples of why someone might need blood (e.g., farming or industrial accidents). The BIT will compare how many patients in each group choose to donate blood. They hypothesize that: 1) patients who receive either message will be more likely to donate than patients who receive no message; and 2) patients who receive the blood-type message will be more likely to donate than those who receive the no-blood-type message. With respect to the latter hypothesis, informing the recipient that they have one of the needed blood types may increase their perception that they are in a semi-unique position to help someone in need as compared to a more general message that may suffer from a diffusion of responsibility effect.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Encouraging Blood Donation in Patients With a Blood Type in Short Supply - Part 2

NCT05825300

Behavior, Health

COMPLETED NA

Blood Donor Competence, Autonomy and Relatedness Enhancement

NCT02717338

Blood Donors

COMPLETED PHASE3

A Survey of Attitudes of Experienced Blood Donors

NCT03102385

Blood Donors

COMPLETED NA

Decreasing ED Utilization by Nudging Patients to Call Their Providers

NCT04567849

Emergency Treatment Telephone Hotlines

COMPLETED NA

The Effect of a Scratch Off Prompt on Health Engagement

NCT01401621

Blood Pressure Check (Hypertension Screening) Cholesterol Test (Lipid Disorder Screening)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Caregivers

The patients in the study will not know that other messages are being sent to other patients, although they will see the text of their own message. Providers will be blind to patient conditions.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No-blood-type message

This group will receive a message that does not mention the patient's blood type, or that the patient's blood type is in short supply.

Group Type EXPERIMENTAL

Patient portal message

Intervention Type BEHAVIORAL

Portal message encourages patients to donate blood

Blood-type message

This group will receive a message that mentions the patient's blood type and that states their blood type is in short supply.

Group Type EXPERIMENTAL

Patient portal message

Intervention Type BEHAVIORAL

Portal message encourages patients to donate blood

Social responsibility

Intervention Type BEHAVIORAL

Message specifies that there is a shortage of the patient's blood type

Shortage control

This group will not receive a message.

Group Type NO_INTERVENTION

No interventions assigned to this group

No-shortage control

This group will not receive a message.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient portal message

Portal message encourages patients to donate blood

Intervention Type BEHAVIORAL

Social responsibility

Message specifies that there is a shortage of the patient's blood type

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented blood type in short supply (for message groups and shortage control group)
* Documented blood type not in short supply (for no-shortage control group)
* Age 18+